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Summary 
Hydrophilic microspheres based on albumin-heparin conjugates have been prepared as a macromolecular delivery system. The 
soluble albumin-heparin conjugate was synthesized and crosslinked in a water-in-oil emulsion with glutaraldehyde to form 
microspheres in the same manner as for albumin microsphere preparation. The microspheres were characterized in terms of their 
size and swelling properties. The loading of macromolecules into albumin-heparin microspheres was carried out concurrently and 
after microsphere preparation. FITC-dextran was applied as a model macromolecule. A higher loading content was achieved when 
loading was carried out concurrently with microsphere preparation than when loaded subsequently. Prolonged release of 
FITC-dextran from albumin-heparin microspheres was achieved and attributed to the high molecular weight of the macromolecule. 
The release of FITC-dextran was modulated by crosslinking density, loading content and the method of drug incorporation. 
Apparently, the mechanism of FITC-dextran release from albumin-heparin microspheres was dependent on the method of drug 
incorporation. For release of FITC-dextran from the microspheres, assuming negligible interactions, a diffusion coefficient of 
1.7 X 10m9 cm2/s was determined. 
Introduction 
Albumin microspheres have been widely inves- 
tigated as biodegradable drug carriers due to 
their potential for site-specific drug delivery in 
vivo by direct injection into discrete anatomical 
compartments and by targeting within the vascu- 
lar system (Tomlinson, 1987). The biodegradation 
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of albumin microspheres results in nontoxic 
byproducts (i.e., amino acids). Microspheres based 
on serum albumin display a high water content 
and a rubbery nature. Albumin microspheres may 
be classified as hydrogels (Heller, 1987) and are 
highly biocompatible (Lee et al., 1981; Ratcliffe 
et al., 1984). While many different drugs have 
been incorporated into albumin microspheres, a 
vast majority have been of low molecular weight 
(e.g., antineoplastics) (Gupta et al., 1988). Cur- 
rently, there exists much interest in the delivery 
of genetically engineered macromolecules due to 
their low oral bioavailability and short plasma 
half-lives. A seminal investigation by Goosen et 
lY2 
al. (1982) demonstrated the possibility of long- 
term insulin release from albumin microspheres 
after subcutaneous injection in vivo. The parame- 
ters influencing insulin release from albumin mi- 
crospheres were not examined. 
The preparation, characterization and in vitro 
release of adriamycin from hydrophilic micro- 
spheres of albumin-heparin conjugates have been 
described previously (Cremers et al., 1990; Kwon 
et al., 1991). Albumin-heparin microspheres are 
hydrogels which exhibit enhanced hydrophilicity 
relative to albumin microspheres, greater col- 
loidal stability and pH- and ionic-strength-depen- 
dent. stimulus-sensitive swelling. Drugs, in princi- 
ple, can bc loaded into the microspheres both 
during and after microsphere preparation through 
a swelling/ deswelling process or ion exchange. 
The objective of this work was to study the re- 
lease of FITC-dextrans from loaded microspheres 
in vitro in order to examine the viability of albu- 
min-based microspheres to deliver macro- 
molecules in a controlled manner. FITC-dextran 
was chosen as a model macromolecule in order to 
simplify the system and to study release behaviors 
of non-interacting solutes with the microsphere 
matrix. 
Materials and Methods 
Materials 
Human serum albumin (lyophilized and crys- 
tallized), olive oil, fluorescein isothiocyanate 
(FIT0 dextrans and 1-ethyl-3-(3-dimethylamino- 
propyl)carbodiimide (EDC) were obtained from 
Sigma, St. Louis, MO. Heparin (lot no. LPP 
060143), from porcine intestinal mucosa, was ob- 
tained from Diosynth, Oss, The Netherlands. Pu- 
rified glutaraldehyde (25% w/v> was purchased 
from Fisher, Pittsburgh, PA. Sodium cyanoboro- 
hydride was obtained from Aldrich, Milwaukee, 
WI. Blue Sepharose CL-6B and dieth- 
ylaminoethyl (DEAE) Sepharose CL-6B were ob- 
tained from Pharmacia, Piscataway, NJ. Micro- 
concavity slides were received from Clay Adams, 
Parsippany, NJ. Cellulose acetate (molecular 
weight cut-off 1000 and 3500) dialysis membranes 
and polytetrafluoroethylene membranes (PTFE) 
(3.0 pm pore size) were obtained from Gelman, 
Ann Arbor, MI. Cellulose acetate membranes 
(8.0 km pore size) were obtained from Milliporc. 
Bedford, MA. Latexes (10 and 100 pm) were 
purchased from Coulter Counter, Hialeah, FL. 
All other chemicals were reagent grade. 
Methods 
Preparation of albumin-heparin microspheres 
Albumin-heparin conjugates were synthesized 
and purified using a slightly modified protocol of 
Hennink et al. (1983). Briefly, serum albumin and 
heparin were coupled via amide bonds using a 
water-soluble carbodiimide (EDC). In this experi- 
ment, a 0.067 M phosphate buffer, pH 5.1 was 
used to maintain the pH of the reaction mixture 
constant in order to preclude the addition of 
concentrated HCI which had resulted in precipi- 
tation during the course of the reaction. The 
conjugate was then purified from free serum al- 
bumin and heparin by Blue Sepharose CL-6B and 
DEAE anion-exchange liquid chromatography, 
respectively. The resulting conjugate was com- 
posed of about 10% heparin by weight (Kwon et 
al., 1991). Albumin-heparin microspheres were 
prepared using a method similar to that of Burger 
et al. (1985). A 140 ml volume of olive oil was 
placed.in a baffled cell and stirred at 300 rpm for 
30 min to stabilize the stirring rate. Albumin- 
hcparin conjugate (100 mg>, dissolved in 400 ~1 
distilled water at 4”C, was injected dropwise into 
stirred olive oil at 25°C and stirring continued for 
15 min. A predetermined amount of purified 
glutaraldehyde (25% w/v) to make l-3% (w/v) 
of the added albumin-heparin conjugate solution 
was then added along with twice the equimolar 
amount of sodium cyanoborohydride solution. 
The crosslinking reaction was allowed to proceed 
for 4 h. Subsequently, 50 ml acetone was added, 
and the emulsion stirred for 1 min. The micro- 
spheres were isolated by centrifugation (MSE, 
VWR, Philadelphia, PA) at 1000 rpm for 10 min. 
The supernatant was then decanted. The micro- 
spheres were resuspended in acetone, collected 
on a 3.0 pm PTFE membrane and washed and 
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dehydrated with acetone. The microspheres were 
air dried for 24 h, vacuum dried for an additional 
24 h and stored frozen in the dark. 
Size analysis 
The diameter of albumin-heparin micro- 
spheres (n = 300) was determined by phase con- 
trast light microscopy (Biophot, Nikon, Tokyo, 
Japan) using a calibrated graticule. Calibration 
was performed with latexes of known diameter. 
The diameters of albumin-heparin microsp)eres 
were measured in the swollen state in isotonic 
phosphate buffer (PBS) (2.00 X 10-j M potas- 
sium phosphate, 8.00 X 10e3 M disodium phos- 
phate, 0.145 M NaCl), pH 7.4 with 0.01% sodium 
azide at 25°C for longer than 1 h to ensure 
equilibrium swelling. 
Swelling 
The equilibrium swelling of albumin-heparin 
microspheres was determined in isotonic PBS, 
0.01% sodium azide, pH 7.4 as previously de- 
scribed Wwon et al., 19911. The swelling ratio 
KW,,,” 
’ = hried (1) 
was determined by measuring the diameter of 
albumin-heparin microspheres and assuming a 
spherical geometry. V is the volume of the micro- 
spheres. 
Drug loading 
For in vitro studies, a model macromolecule, 
FITC-dextran (M, = 17 200), was loaded concur- 
rently with albumin-heparin microsphere prepa- 
rations. Varying amounts of FITC-dextran (2.50- 
10.0 mg) were dissolved along with the albumin- 
heparin conjugate, and the microspheres were 
prepared as described. The FITC-dextran was 
not expected to participate in the crosslinking 
reaction during the formation of the albumin- 
heparin microspheres. The amount of FITC-dex- 
tran incorporated into the microspheres was de- 
termined by the method of Tomlinson and Burger 
(1985). Albumin-heparin microspheres were pre- 
pared with FITC-dextran added as described 
without crosslinking agent. The marginally stable 
microspheres were placed in isotonic PBS, pH 
7.4, 0.01% sodium azide, where they readily un- 
derwent dissolution and released the loaded 
FITC-dextran. The extent of loading was quanti- 
tated by measuring the absorbance at 494 nm 
with a UV/Vis spectrophotometer (Lambda 7, 
Perkin Elmer, Norwalk, CT). 
The potential for loading macromolecules into 
albumin-heparin microspheres after microsphere 
preparation was investigated. To examine the 
loading via a swelling/ deswelling process, albu- 
min-heparin microspheres (100 mg, 2% w/v glu- 
taraldehyde) with a relatively low degree of 
crosslinking of which swelling was sensitive to 
ionic strength were swollen in 10.0 ml solution of 
FITC-dextran in deionized water. The concentra- 
tion of FITC-dextran used was 2.50 mg/ml. The 
loading experiments were carried out for 50 h at 
25°C with constant agitation. The loading of 
FITC-dextran into albumin-heparin microspheres 
(100 mg, 3% w/v glutaraldehyde), of which 
swelling was relatively insensitive to ionic strength, 
was also carried out in 10.0 ml isotonic PBS, with 
0.01% sodium azide, pH 7.4 under otherwise 
identical experimental conditions. This loading 
procedure was utilized to obtain an estimate of 
the diffusion coefficient of the dextran under 
identical conditions with loading and release 
studies. Albumin-heparin microspheres were then 
isolated by vacuum filtration on a cellulose ac- 
etate membrane (pore size 8.0 pm>, dehydrated 
with acetone on a PTFE membrane, air dried and 
then vacuum dried. The incorporation of FITC- 
dextran into albumin-heparin microspheres (50.0 
mg) was measured by determining the amount 
released in 10 ml deionized water during a period 
of 100 h. 
In vitro release studies 
Albumin-heparin microspheres (50.0 mg) 
loaded with FITC-dextran were placed in 10.0 ml 
isotonic PBS with 0.01% sodium azide, pH 7.4 at 
37°C. The vials were then placed in a shaking 
waterbath (BT-47, American Scientific Products, 
McGaw Park, IL) and agitated at 100 strokes/ 
min. The release medium was assayed at appro- 
priate time intervals by withdrawing 1.00 ml sam- 
194 
ples and replacing with 1.00 ml isotonic PBS with 
0.01% sodium azide, pH 7.4 to maintain a con- 
stant volume of 10.0 ml. This dilution was ac- 
counted for when establishing the release kinet- 
ics. The amount of FITC-dextran released was 
quantitated by measuring the absorbance at 494 
nm by UV/Vis spectrophotometry. 
Results and Discussion 
Albumin microspheres are formed by chemi- 
cal- and heat-induced crosslinking, and drugs may 
be incorporated into albumin microspheres con- 
currently with microsphere preparation. For this 
study, albumin-heparin microspheres were chemi- 
cally crosslinked. This route was quite facile and 
has been routinely used for the drug loading of 
albumin microspheres (Tomlinson and Burger, 
1985). Swollen albumin-heparin microspheres in 
isotonic PBS, pH 7.4, prepared as described above 
had average diameters of 140 f 90, 120 + 80 and 
85 + 50 pm on crosslinking at 1, 2 and 3% w/v 
glutaraldehyde, respectively. No significant batch 
to batch variation was observed. The size of mi- 
crospheres was normally distributed and was due 
to the use of a baffled cell (Tomlinson and Burger, 
1985). The preparation parameters (e.g., oil phase 
volume, stirring rate) were adjusted in order to 
prepare relatively larger microspheres to achieve 
long-term release of the FITC-dextrans. 
For this study, FITC-dextran was used as a 
model macromolecule. This model compound had 
a low polydispersity (M,/M, < 1.5) and was 
readily assayed. The FITC-dextrans had a weight 
average molecular weight of 17 200. Interactions 
of the FITC-dextran with the microspheres were 
expected to be weak. Macromolecules are good 
candidates for sustained release from albumin- 
heparin microspheres due to their lower diffusiv- 
ity (i.e., on the order of 10-h-10-7 cm’/s) (Tyn 
et al., 1990) relative to low molecular weight 
solutes which have diffusivities on the order of 
lo-” cm*/s (Bird et al., 1960). The release of low 
molecular weight drugs from albumin micro- 
spheres is typically biphasic with an initial rapid 
release followed by a much slower first-order 
release (Tomlinson, 1985). Within 5 min, up to 
Ok”‘.“““.““.‘.“.“‘,‘. 
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Fig. I. Release of FITC-dextran (4’7~ w/w loading content) 
from albumin-heparin microspheres of varying crosslinking 
density. Loading during preparation of microspheres. Mean + 
SD (n = 3). 
95% drug release has been observed from albu- 
min microspheres during that nascent period of 
release. Heat-crosslinked albumin microspheres 
exhibit substantially slower release than chemi- 
cally crosslinked microspheres. Transport mecha- 
nisms of macromolecules from albumin micro- 
spheres have not been clearly elucidated. Macro- 
molecular transport mechanisms through hydro- 
gel membranes have been investigated (Sato and 
Kim, l.984; Gilbert et al., 1988; Pitt, 1990), and 
macromolecules were observed to permeate pre- 
dominantly via the ‘pore’ mechanism. 
Tomlinson (1985) has discussed the parame- 
ters influencing the release of drugs from albu- 
min microspheres. The effects of crosslinking 
density, actual loading content and loading pro- 
cess on macromolecule release from albumin- 
heparin microspheres were ascertained. In Fig. 1, 
the effects of crosslinking of the albumin-heparin 
microspheres on the release of FITC-dextran are 
illustrated. A nascent period of rapid release was 
observed followed by a period of sustained re- 
lease. The nascent release of FITC-dextran de- 
creased as the crosslinking density increased. The 
latter phase of sustained release was apparently 
independent of crosslinking density. Peppas and 
Reinhart (1983) showed that by increasing the 
crosslinking density of a hydrogel network, the 
effective mesh size (i.e., pore size) of the hydrogel 
decreased, and solute transport became hin- 
dered. At high crosslinking density, proteins may 
be physically immobilized in hydrogel networks 
(Keyes and Saraswathi, 1985). Albumin-heparin 
microspheres crosslinked at 1, 2 and 3% w/v 
glutaraldehyde had swelling ratios of 7.5, 5.0 and 
2.6, respectively. The swelling of the micro- 
spheres was rapid (i.e., < 15 min) and was as- 
sumed to have no influence on the release kinet- 
ics after that time period. From Fig. 1 it is appar- 
ent that loading FITC-dextran concurrently with 
microsphere preparation resulted in FITC-de- 
xtran physically immobilized in the microspheres, 
the amount being dependent on the crosslinking 
density. This may be due to the high molecular 
weight of the FITC-dextran which resulted in 
chain entanglement within the microsphere net- 
work and would account for the latter period of 
prolonged release. 
The amount of drug loading was adjusted to 
alter the release of FITC-dextran from albumin- 
heparin microspheres (Fig. 2). When the loading 
content of FITC-dextran was increased from 2 to 
7% w/w, the initial release of FITC-dextran from 
albumin-heparin microspheres (2% w/v glu- 
o 2% 
l 4% 
10 . 7% 
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Fig. 2. Release of FITC-dextran from albumin-heparin micro- 
spheres (2% w/v glutaraldehyde) of varying loading content. 
Loading during preparation of microspheres. Mean k SD 
(Fl = 3). 
n High Swellmg 
[Drug] +> ) 
Fig. 3. Schematic illustration of drug loading and release using 
the stimulus-sensitive swelling properties of albumin-heparin 
microspheres. 
taraldehyde) increased. Subsequent sustained re- 
lease did not vary with increased drug loading. 
Another way of loading drugs into synthetic 
hydrogels has been through use of their 
stimulus-sensitive swelling properties. Modula- 
tion of swelling for the drug loading of hydrogels 
has been carried out by varying the solvent com- 
position (Forni et al., 1989). Temperature and pH 
have also been utilized as external stimuli to 
modulate the swelling of hydrogels in aqueous 
solutions in order to load drugs (Hoffman et al., 
1986; Kou et al., 1988). External stimuli such as 
high pH and low ionic strength may induce the 
albumin-heparin microspheres to swell consider- 
ably (Kwon et al., 1991). This results in drugs 
being able to diffuse quickly into the matrix (Fig. 
3). The release of drug from the albumin-heparin 
microspheres was carried out at a lower swelling 
state (i.e., physiological pH and ionic strength) 
where the diffusivity through the microsphere 
matrix of the drug was lower due to a reduction 
in swelling level. The pH-dependent swelling of 
albumin-based microspheres may also be used for 
site-specific delivery within the gastrointestinal 
tract (Farhadieh, 1975). The microspheres exhibit 
a low degree of swelling in the stomach and 
protect the drug, releasing the drug at the higher 
pH of the small intestine. By carrying out drug 
loading in an aqueous system, the stability of 
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macromolecules to be loaded may be increased 
compared to loading with organic solvents. For 
albumin-based microspheres, drug loading after 
microsphere preparation may be advantageous if 
drugs are unstable when incorporated concur- 
rently with microsphere preparation. Proteins and 
peptides may be covalently modified if the 
molecules contain functional groups which react 
with the crosslinking agent. A loading content of 
0.53% w/w of FITC-dextran into albumin- 
heparin microspheres (2% w/v glutaraldehyde) 
was achieved by a swelling/deswelling process. 
The kinetics of FITC-dextran release from albu- 
min-heparin microspheres loaded via a swelling/ 
deswelling process is shown in Fig. 4. Compared 
to the case when FITC-dextran was loaded con- 
currently with albumin-heparin microsphere 
preparation, lower loading was attained, a greater 
fraction of the FITC-dextran was released and 
release was relatively fast. This was likely due to 
the FITC-dextran being largely associated with 
the ‘pore’ domain of the microspheres when load- 
ing was carried out after microsphere prepara- 
tion. The low loading content may also be caused 
by the dehydration process after the micro- 
spheres have been collected from the FITC-dex- 
tran loading solution. FITC-dextran was possibly 
f 
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Fig. 4. Release of FITC-dextran (0.53% w/w loading content) 
from albumin-heparin microspheres (2% w/v glutaraldehyde) 
loaded via swelling/deswelling piocess. Mean f SD (n = 3). 
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Fig. 5. Release of FITC-dextran (0.58% w/w loading content) 
from albumin-heparin microspheres (3% w/v glutaraldehyde) 
loaded after microsphere preparation in isotonic PBS, pH 7.4. 
25°C. Mean + SD (n = 3). 
removed, along with water, when the micro- 
spheres were dehydrated with acetone. Similar 
results were observed for the release of low 
molecular weight drugs from polyvinylalcohol 
particles loaded concurrently and after micropar- 
title preparation (Gander et al., 19901, and it was 
postulated that when drugs were loaded concur- 
rently with microparticle preparation, drug could 
be associated with regions of high crosslinking, 
with release occurring slowly. When drugs were 
loaded after microparticle preparation, drugs 
were likely to diffuse into regions having a lower 
degree of crosslinking (i.e., pore domain) and to 
be released more rapidly. 
Fig. 5 shows the release of FITC-dextran 
loaded after microsphere preparation (0.58% 
w/w) under isotonic conditions. Albumin-heparin 
microspheres at 3% w/v glutaraldehyde exhibit 
swelling which is largely insensitive to pH and 
ionic strength. The release was rapid, and all of 
the FITC-dextran was released. Release occurred 
more rapidly than when the microspheres were 
loaded by a swelling/deswelling process and was 
ascribed to less physically entangled FITC-dex- 
tran. Presumably all the FITC-dextran was re- 
leased from the albumin-heparin microspheres by 
diffusion via the pore mechanism (Sate and Kim, 
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1984; Gilbert et al., 1988). The time for half-frac- 
tion release of solutes assuming diffusion with 
low extent of interaction with microspheres may 
be determined from 
t so%, = 0.030r2/D 
where r is the radius of the sphere, and D 
denotes the diffusion coefficient (Baker and Kim, 
1974). Assuming a radius of 100 pm and a t,,, 
of 7.5 min, an estimate for a diffusion coefficient 
of 1.7 x lo-” cm2/s was obtained which was simi- 
lar to values determined for the transport of 
macromolecules through hydrogels (Sato and 
Kim, 1984; Gilbert et al., 1988). This suggested 
that the rapid release was due to the high specific 
surface area of the microspheres. Therefore, the 
nascent period of rapid release observed from 
albumin-heparin microspheres in the case of 
FITC-dextran loaded concurrently with micro- 
sphere preparation may be due to diffusion 
through the pore pathway, and the sustained re- 
lease from FITC-dextran physically entrapped in 
the microspheres taking place more slowly. 
Conclusions 
The loading of FITC-dextran into albumin- 
heparin microspheres was accomplished both 
concurrently with and after microsphere prepara- 
tion. A higher loading content of FITC-dextran 
was achieved when loading was carried out con- 
currently with microsphere preparation (7.0% 
w/w) than when performed subsequently (0.58% 
w/w). When loaded concurrently, an initial pe- 
riod of rapid release from albumin-heparin mi- 
crospheres of FITC-dextran was observed which 
most likely occurred by diffusion via the pore 
mechanism. The initial release of FITC-dextran 
was modulated by crosslinking and drug loading. 
A longer period of sustained release was then 
observed and was attributed to the release of 
entangled FITC-dextran. The FITC-dextran, 
when loaded after microsphere preparation, was 
released more quickly, predominantly occurring 
via the pore mechanism. The release of FITC- 
dextran from albumin-heparin microspheres was 
observed to be prolonged to a greater extent than 
the release of low molecular weight drugs from 
chemically crosslinked albumin microspheres and 
was due to the high molecular weight of the 
dextran. Albumin-heparin microspheres, by virtue 
of their hydrophilicity and release properties, may 
be used as drug carriers and warrant further 
investigation. 
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